Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Niemann-pick diseases
MeSH D009542 - niemann-pick diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D013106:
Sphingolipidoses
0 Companies
0 Drugs
Success rate
D015616:
Non-langerhans-cell histiocytosis
0 Companies
0 Drugs
Success rate
D009542:
Niemann-pick diseases
1 Company
1 Drug
$
Success rate
D052536:
Type a niemann-pick disease
0 Companies
0 Drugs
Success rate
D052537:
Type b niemann-pick disease
0 Companies
0 Drugs
Success rate
D052556:
Type c niemann-pick disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Johnson & Johnson
Miglustat
Zavesca
2002-11-20
Clinical Trials
Historical Success Rate
Phase 1
33
%
1/3
Phase 2
67
%
2/3
Phase 3
33
%
1/3
Approved:
1
Overall Success rate:
7%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use